Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangming Li

Showing results (211-220 of 216) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 216 results.
Plos One|November 9, 2013
A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesNeal N Padte, Mar Boente-Carrera, Chasity D Andrews, et al.
Plos One|September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidateAmy R Noe, Diego Espinosa, Xiangming Li, et al.
The Journal of Experimental Medicine|February 9, 2024
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.
Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.
JCI Insight|April 30, 2026
PD-1-targeted IL-15 mutein activates CD8+ and CD4+ T cells in infection and cancerIsaraphorn Pratumchai, Marie Bernardo, Julien Tessier, et al.
Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Pageof 22

Showing results (211-220 of 216) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Plos One|November 9, 2013
A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesNeal N Padte, Mar Boente-Carrera, Chasity D Andrews, et al.
Plos One|September 24, 2014
A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidateAmy R Noe, Diego Espinosa, Xiangming Li, et al.
The Journal of Experimental Medicine|February 9, 2024
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapyLei Wang, Yufeng Xiao, Yuewan Luo, et al.
Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.
JCI Insight|April 30, 2026
PD-1-targeted IL-15 mutein activates CD8+ and CD4+ T cells in infection and cancerIsaraphorn Pratumchai, Marie Bernardo, Julien Tessier, et al.
Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Pageof 22